These brain-altering meds linked to falls and confusion are being prescribed to 25% of older adults with dementia

While all medications carry potential side effects, certain types have been shown to increase the risk of falls, confusion ...
McKnight's Long-Term Care News

One in four older Americans with dementia is prescribed high-risk CNS meds, study finds

About 25% of Medicare beneficiaries with dementia were prescribed high-risk central nervous system (CNS) – active medications associated with falls, confusion and hospitalizations between 2013 and ...
FierceBiotech

Lilly pulls out of CNS portion of $960M RIPK1 inhibitor collab with Rigel

Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...
PharmiWeb

Central Nervous System (CNS) Therapeutics Strategic Business Report 2025-2030 - Biologics, Gene Therapies, and Small Molecules Converge in Development Pipelines for CNS ...

DUBLIN--(BUSINESS WIRE)--The "Central Nervous System Therapeutics Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Central Nervous ...